Melanóma: vizsgálatok itt: Olaszország

In Olaszország 61 Also abroad 578

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

3. fázisTaking people
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Where
Milan, Naples, Rome
Életkor
18 év and over
People
290 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00
No phaseTaking people
The Multicentre Selective Lymphadenectomy Trial - 3
Where
Perugia
Életkor
18 év and over
People
1500 worldwide
Run by
Melanoma Institute Australia
See details and how to joinNCT07049276
3. fázisTaking people
Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)
Where
Catanzaro, Siena
Életkor
18 év and over
People
119 worldwide
Run by
Mabxience Research S.L.
See details and how to join2025-521562-95-00 · EU 2025-521562-95-00
3. fázisTaking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Florence, Milan, Naples, Pisa, Rome
Életkor
18 év and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
1/2. fázisTaking people
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Where
Milan, Naples, Rome, Verona
Életkor
18 év and over
People
240 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00
3. fázisTaking people
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Where
Naples, Padova, Perugia, Roma, Rome, Siena
Életkor
18 év and over
People
180 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT05522660
1. fázisTaking people
A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma
Where
Meldola, Siena
Életkor
18 év and over
People
83 worldwide
Run by
Celltrion Inc.
See details and how to join2023-510017-26-00 · EU 2023-510017-26-00
No phaseTaking people
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Where
Padova
Életkor
18 év to 99 év
People
24
Run by
Istituto Oncologico Veneto IRCCS
See details and how to joinNCT06753136
2/3. fázisTaking people
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Where
Milan, Naples, Rome
Életkor
18 év and over
People
280 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00
No phaseTaking people
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
Where
Candiolo
Életkor
18 év and over
People
850
Run by
Fondazione del Piemonte per l'Oncologia
See details and how to joinNCT07469709
3. fázisTaking people
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Where
Milan, Naples, Perugia, Rome, Siena
Életkor
18 év and over
People
540 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00
3. fázisTaking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Bari, Bergamo, Meldola, Milan, Modena, Naples, Padova, Perugia, Ponderano, Roma, Siena, Torino
Életkor
18 év and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
No phaseTaking people
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Where
Palermo, Perugia
Életkor
1 év and over
People
300
Run by
Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630
No phaseTaking people
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
Where
Genoa
Életkor
18 év to 39 év
People
25
Run by
Ente Ospedaliero Ospedali Galliera
See details and how to joinNCT06994208
No phaseTaking people
Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria
Where
Modena
Életkor
18 év and over
People
300
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT07251335
3. fázisTaking people
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Where
Milan, Naples, Perugia, Rome, Rozzano, Siena
Életkor
18 év and over
People
186 worldwide
Run by
Philogen S.p.A.
See details and how to joinNCT03567889 · EU 2023-507119-36-00
No phaseTaking people
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
Where
Modena
Életkor
18 év and over
People
200
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT07277920
No phaseNot yet taking people in Olaszország
Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
Where
Milan
Életkor
18 év and over
People
600 worldwide
Run by
OncoHost Ltd.
See details and how to joinNCT07246759
No phaseTaking people
Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma
Where
Naples
Életkor
18 év and over
People
20
Run by
Fondazione Melanoma Onlus
See details and how to joinNCT06880198
No phaseTaking people
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
Where
Bari, Genova, Milan, Modena, Naples, Padova, Perugia, Roma, Siena, Torino
Életkor
Up to 40 év
People
270
Run by
Intergruppo Melanoma Italiano
See details and how to joinNCT07092670
2. fázisTaking people
Hepatic radiotherapy added to standard of care for the treatment of HLA A*02:01 positive Metastatic Uveal Melanoma patients
Where
Rome
Életkor
18 év and over
People
20
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to join2024-519760-40-00 · EU 2024-519760-40-00
No phaseTaking people
An International Study on Pediatric Patients With Rare Tumors.
Where
Padova
Életkor
0 év to 18 év
People
6250
Run by
Azienda Ospedaliera di Padova
See details and how to joinNCT07072143
No phaseTaking people
Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study
Where
Bari, Milan, Perugia, Torino
Életkor
18 év and over
People
35
Run by
Azienda Ospedaliera di Perugia
See details and how to joinNCT07050940
No phaseTaking people
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Where
Milan
Életkor
18 év to 90 év
People
1000
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05621837
No phaseTaking people
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
Where
Pavia
Életkor
18 év and over
People
250
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06899789